BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: van Geer MA, Bakker CT, Koizumi N, Mizuguchi H, Wesseling JG, Oude Elferink RP, Bosma PJ. Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivoWorld J Gastroenterol 2009; 15(22): 2754-2762 [PMID: 19522026 DOI: 10.3748/wjg.15.2754]
URL: https://www.wjgnet.com/1007-9327/full/v15/i22/2754.htm
Number Citing Articles
1
Michael Behr, Johanna K. Kaufmann, Patrick Ketzer, Sarah Engelhardt, Martin Mück-Häusl, Pamela M. Okun, Gabriele Petersen, Frank Neipel, Jessica C. Hassel, Anja Ehrhardt, Alexander H. Enk, Dirk M. Nettelbeck, Ilya Ulasov. Adenoviruses Using the Cancer Marker EphA2 as a Receptor In Vitro and In Vivo by Genetic Ligand Insertion into Different Capsid ScaffoldsPLoS ONE 2014; 9(4): e95723 doi: 10.1371/journal.pone.0095723
2
Karoly Toth, Debanjan Dhar, William SM Wold. Oncolytic (replication-competent) adenoviruses as anticancer agentsExpert Opinion on Biological Therapy 2010; 10(3): 353 doi: 10.1517/14712590903559822
3
Bethany Powell Gray, Kathlynn C. Brown. Combinatorial Peptide Libraries: Mining for Cell-Binding PeptidesChemical Reviews 2014; 114(2): 1020 doi: 10.1021/cr400166n
4
Yue Pan, Xuewen Du, Fan Zhao, Bing Xu. Magnetic nanoparticles for the manipulation of proteins and cellsChemical Society Reviews 2012; 41(7): 2912 doi: 10.1039/c2cs15315g
5
Ruiwu Liu, Xiaocen Li, Wenwu Xiao, Kit S. Lam. Tumor-targeting peptides from combinatorial librariesAdvanced Drug Delivery Reviews 2017; : 13 doi: 10.1016/j.addr.2016.05.009
6
Sayantan Mitra, Srinivas Duggineni, Mitchell Koolpe, Xuejun Zhu, Ziwei Huang, Elena B. Pasquale. Structure−Activity Relationship Analysis of Peptides Targeting the EphA2 ReceptorBiochemistry 2010; 49(31): 6687 doi: 10.1021/bi1006223
7
C Puig-Saus, L A Rojas, E Laborda, A Figueras, R Alba, C Fillat, R Alemany. iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacyGene Therapy 2014; 21(8): 767 doi: 10.1038/gt.2014.52
8
Otto Hemminki, Akseli Hemminki. Gene Therapy of Cancer2014; : 153 doi: 10.1016/B978-0-12-394295-1.00011-1
9
J PosthumaDeBoer, S R Piersma, T V Pham, P W van Egmond, J C Knol, A M Cleton-Jansen, M A van Geer, V W van Beusechem, G J L Kaspers, B J van Royen, C R Jiménez, M N Helder. Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug deliveryBritish Journal of Cancer 2013; 109(8): 2142 doi: 10.1038/bjc.2013.578
10
Elena B. Pasquale. Eph receptors and ephrins in cancer: bidirectional signalling and beyondNature Reviews Cancer 2010; 10(3): 165 doi: 10.1038/nrc2806
11
S. A. Zozulya, I. P. Udovichenko. Eph family receptors as therapeutic targetsRussian Journal of Bioorganic Chemistry 2012; 38(3): 231 doi: 10.1134/S106816201203017X